Navigating Delta-8 THC Regulatory Changes and Patient Access Concerns
Delta-8 THC regulatory changes are tightening access to hemp-derived products. Patients relying on delta-8 THC for symptom management face uncertainty as regulations evolve. Clinicians must understand these changes to guide patient care effectively.
TN Concerned for Public Health After 600+ Illegal Hemp Retailers Busted
The rise of illegal hemp retailers in Tennessee creates significant public health concerns due to unregulated products exceeding legal THC limits. Clinicians must recognize the risks posed by illegal hemp retailers to patient safety, including…
New Research Reveals Smartwatch Technology May Detect Cannabis Intoxication in Real Time
Smartwatch cannabis intoxication detection offers a novel approach to objectively assess impairment in real time. This technology analyzes physiological markers to identify acute intoxication. It holds promise for improving clinical and safety…
New Study Links Cannabis Vaping to Controversial Vomiting Syndrome
Cannabinoid hyperemesis syndrome vaping is linked to severe cyclic vomiting that can impair quality of life. This syndrome is increasingly associated with high-potency cannabis vaping products. Awareness of this condition helps clinicians diagnose and…
Cannabis Compounds CBD and CBG Show Promise in Fighting Fatty Liver Disease
Emerging cbd and cbg fatty liver research suggests these compounds may help modulate lipid accumulation and inflammation. This research offers hope for new therapeutic options in fatty liver disease. However, clinical trials are needed before…
In the Mix: 8 More Articles — March 12, 2026
This article reviews the cannabinoid clinical relevance threshold in recent cannabis market developments. Eight articles scored below the threshold, highlighting challenges in clinical evidence. Understanding this threshold helps clinicians navigate…
IRS Disputes Cannabis Company’s Tax Argument (Newsletter: March 12, 2026)
Cannabis companies tax disputes with the IRS create financial uncertainty that may affect product pricing and availability for patients who depend on medical cannabis. The ongoing tax disputes highlight federal barriers to cannabis industry legitimacy…
Marijuana – Point of View
Cannabis safety research is essential for clinicians to provide informed counseling about cannabis risks. Emerging evidence highlights the importance of understanding adverse effects. This research supports balanced clinical guidance on cannabis use.
Policy Watch: 20 Regulatory Updates — March 12, 2026
This Policy Watch highlights cannabis regulatory updates March 2026, focusing on federal scheduling and Medicare policy changes. These updates impact cannabis clinicians' prescribing authority and patient access. Stay current with the latest cannabis…
We as a couple ??
When both partners have chronic pain and finally understand why the other keeps canceling plans, the relationship dynamic shifts considerably. Via r/weed Further Reading CED Clinic BlogCannabis-Infused Beverages as Alcohol Alternatives: New York at Five…